Estrogen and Heart Health: What We Believe Now
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
After the initial findings from the Women’s Health Initiative were published, hormone replacement therapy in menopause stopped practically overnight. But the first analysis may not be the last word. Our guest today is Dr. Richard Karas, Professor of Medicine at the Tufts University School of Medicine in Boston. He has several titles including: Co-Director, Molecular Cardiology Research Center, Director, Preventive Cardiology and Director, Women’s Heart Center at the New England Medical Center. He received his MD from Tufts and his Ph.D in Physiology from Harvard. We are discussing the effects of hormone replacement therapy in menopause on the risk of cardiovascular disease.
Overview
After the initial findings from the Women’s Health Initiative were published, hormone replacement therapy in menopause stopped practically overnight. But the first analysis may not be the last word. Our guest today is Dr. Richard Karas, Professor of Medicine at the Tufts University School of Medicine in Boston. He has several titles including: Co-Director, Molecular Cardiology Research Center, Director, Preventive Cardiology and Director, Women’s Heart Center at the New England Medical Center. He received his MD from Tufts and his Ph.D in Physiology from Harvard. We are discussing the effects of hormone replacement therapy in menopause on the risk of cardiovascular disease.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Level Up Your Skills: Tailoring Management of HF
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?